LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will participate on a panel at BioFlorida's 10th annual conference titled "Raising Capital" on October 17 in Weston, FL.
News | 10. 17. 2007
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.